Eleanor Hayward is a Health Correspondent for The Times, with a focus on national health issues in the United Kingdom. She has also had her work featured in The Australian. Eleanor covers a wide range of topics in the health field, including medical research, public health initiatives, and healthcare policies.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Eleanor's articles mainly focus on healthcare, medical research, and public health issues within the United Kingdom. Her coverage emphasizes citing data and government announcements. Therefore, she is likely to be interested in pitches that provide access to reliable data or insights from credible experts in the healthcare sector.
Given Eleanor’s extensive use of data and her focus on government announcements related to health, she would likely respond well to pitches offering exclusive access to new research findings, interviews with leading healthcare professionals or policymakers, or analyses of important public health trends specifically relevant to the UK.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The former health secretary said care was being held back for sufferers of the neurological disorder because of a lack of specialist NHS services
A study found adults following the personalised nutrition programme Zoe saw far greater benefits than those following ‘one size fits all’ official guidelines
By: Eleanor Hayward
Opal Sandy from Oxfordshire is first child in the world to take part in the trial of a revolutionary technique
Harvard researchers followed the diets of 100,000 adults over more than 30 years
Researchers analysed health records of the first 200 runners to achieve the feat
A study confirmed that obesity causes 13 types of cancer including breast and bowel, and identified a further 19 types associated with weight gain
Parents urged to avoid having meals in front of the TV and to ensure dinner tables are phone-free spaces so children develop good habits
‘Sick-note culture’ is costing the UK £98 billion a year or 4 per cent of GDP
By: Eleanor Hayward
Scientists are dubbing retatrutide the ‘Godzilla’ of weight loss jabs
Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in guidelines is needed to allow routine prescriptions
(833) 317-6278 
